Preventing Relapse: The Role of LAIs in Schizophrenia
From Psychopharmacology and Psychiatry Updates · · 7 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning.
Faculty: Brian Miller, M.D., Ph.D., M.P.H. Host: Richard Seeber, M.D.
- Learn more about our memberships here
- Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia
- Understanding When to Prescribe LAIs
Back to Psychopharmacology and Psychiatry Updates · Report a problem